Drug discovery startup Congruence Therapeutics closes $20 million CAD extension of Series A
Posted in General

Drug discovery startup Congruence Therapeutics closes $20 million CAD extension of Series A

BDC Capital’s Thrive Venture Fund joined to lead the extension. Congruence Therapeutics has secured an additional $20 million CAD ($15 million USD) for its…

Continue Reading Drug discovery startup Congruence Therapeutics closes $20 million CAD extension of Series A